Research & Development

av天堂av电影亚洲色图港股通(沪)净流入13.67亿 港股通(深)净流入5.54亿


  霍去病就跨坐在一條板凳上,目光一瞬不瞬的盯著正在吃飯的於單,何愁有身著官衣殷勤的給於單布菜。   這是安靜,無聊的一天……av天堂   “敢把頭抬起來就剜掉你的眼楮!”av电影   想要獲得純銅只有一個法子——那就是電解!!!   “呀,松鼠冬天都如此忙碌,看來是一群懶松鼠啊。”亚洲色图   “兩年前,我父親與小梁王,城陽王三家聯合出兵,全軍四千一百三十二名甲士,全部都是軍中最彪悍的猛士。一場仗打下來,即便是我也中了暗算,我腰上的那個傷疤單于是見過的,我身為翁主都幾乎性命不保,您以為軍中那些悍卒會是一個什麼下場?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo